期刊文献+

载脂蛋白E基因多态性和动脉瘤性自发蛛网膜下腔出血预后相关性 被引量:12

The influence of APOE gene polymorphism on the prognosis of spontaneous aneurysmal subarachnoid hemorrhage (SAH)
下载PDF
导出
摘要 目的 探讨载脂蛋白E(ApoE)基因多态性和动脉瘤性自发蛛网膜下腔出血 (SAH)预后的关系。 方法 对 10 4例动脉瘤性SAH患者采用哥拉斯格预后评分 (GOS) ,对伤后 3个月的恢复情况进行评估。测定患者的血脂ApoE基因多态性 ,通过限制性片段长度多态性而确定 (RFLP)。结果 病例组的基因型和等位基因频率与正常对照组无显著性差异 (P >0 .0 5 )。在 18例ApoE∈ 4等位基因携带者中有 5例 (2 7.8% )预后不良 ,明显高于非∈4等位基因携带者 (8.1% ,P =0 .0 32 ) ;单因素和多因素Logistic回归均提示仅∈ 4是预后不良的危险因素 (单因素OR =4 .34,P =0 .0 2 6 ;多因素OR =6 .95 ,P =0 .0 30 )。结论 APOE∈ 4等位基因是动脉瘤性SAH患者预后不良的危险因素。 Objective To explore the relationship between APOE gene polymorphism and the prognosis of spontaneous aneurysmal subarachnoid hemorrhage (SAH).Methods A total of 104 patients with aneurysmal SAH were studied.The results were evaluated with glasgow outcome scale (GOS) 3 months after SAH.The levels of patients serum lipid were measured.The APOE polymorphism was determincd by PCR followed by RFLP.Results The distributions of APOE genotypes and alleles in patients matched that in control subjects.That 5 of 18 patients with APOE ∈4 (28%) had an infavorable results is significantly different from those without APOE ∈4 (7/86,8%) (χ 2, P =0.032;univariate logistic regression,or=4.34,95% CI 1.20~15.75, P =0.026).However neither the presence of ∈2 nor ∈3 was significantly different from these absent of it.The relative hagard of APOE ∈4 for unfavorable results still remained after adjustment for clinical assessment (OR=6.95;95% CI 1.21~39.75, P =0.030).Serum total cholesterol,low density lipoprotein cholesterol and apolipoprotein B were higher in patients with unfavorable results than in those with favorable ones.Conclusions Our findings showed that the patients with APOE ∈4 allele predispose unfavorble result after aneurysmal SAH,although there may be no association of APOE with incidence of aneurysmal SAH.
出处 《北京医学》 CAS 北大核心 2003年第3期147-150,共4页 Beijing Medical Journal
基金 国家自然科学基金资助项目 (批准号 3 0 0 70 771)
  • 相关文献

参考文献9

  • 1汤劼,赵继宗.载脂蛋白E多态性和脑血管疾病[J].国外医学(脑血管疾病分册),2002,10(3):198-200. 被引量:5
  • 2Niskakangas T, OEhman J, Niemelae M, et al. Association of apolipoprotein E polymorphism with outcome after aneurysmal subarachnoid hemorrhage: a preliminary study. Stroke, 2001,32 : 1181 - 1184.
  • 3Clarence HS, Leung WS, Poon LM, et al. Apolipopmtein E genotype and outcome in aneurysmal subarachnoid hemorrhage. Stroke, 2002, 33 : 548- 552.
  • 4Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res, 1990,31:545-548.
  • 5Liaquat 1, Dunn LT, Nicoll JA, et al. Effect of apolipoprotein E genotype on hematoma volume after trauma. J Neurosurg, 2002,96 : 90 -96.
  • 6Teasdale GM, Nicoll JA, Murray G, et al. Association of apolipoprotein E polymorphism with outcome after head iniury. Lancet, 1997, 350:1069- 1071.
  • 7Paris D, Town T, Parker TA, et al. lsoform-specific vasoconstriction induced by apolipoprotein E and modulation of this effect by Alzheimer' s beta-amyloid peptide. Neurosci Lett, 1998,256 : 73- 76.
  • 8Friedman G, Froom P, Sazbon L, et al. Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury, Neurology, 1999,52 : 244 - 248.
  • 9Amarenco P. Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction. Neurology, 2001,57(Suppl) : S35 - S44.

二级参考文献24

  • 1Mahley RW, Huang Y. Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. Curr Opin Lipidol, 1999, 10(3):207-217.
  • 2Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci, 1994, 17(12): 525-530.
  • 3McCarron MO, Delong D, Aberts MJ. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology, 1999, 53(6): 1308-1311.
  • 4McCarron MO, Muir KW, Nicoll JA, et al. Prospective study of apolipoprotein E genotype and functional outcome following ischemic stroke. Arch Neurol, 2000, 57(10): 1480-1484.
  • 5Pedro-Botet J, Senti M, Nogues X, et al. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism.Stroke, 1992, 23 (11 ): 1556-1562.
  • 6Couderc R, Mahieux F, Bailleul S, et al. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study. Stroke, 1993, 24(5): 661-664.
  • 7Kessler C, Splzer C, Stauske D, et al. The apolipoprotein E and β-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease. Arterioscler Thromb Vasc Biol, 1997, 17(11): 2880-2884.
  • 8Margaglione M, Seripa D, Gravina C, et al. Prevalence of apolipoprotein E alleles in heathy subjects and survivors of ischemic stroke: an Italian Case-Control Study. Stroke, 1998, 29(2): 399-403.
  • 9Ji Y, Urakami K, Alachi Y, et al. Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease. Dement Geriatr Cogn Disord, 1998, 9(5):243 -245.
  • 10Aberts MJ, Graffagnino C, McClenny C, et al. ApoE genotype and survival from intracerebral haemorrhage. Lancet, 1995 , 346(8974):575.

共引文献4

同被引文献162

引证文献12

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部